1. Burger J.A., Wiestner A. Targeting B cell receptor signalling in cancer: preclinical and clinical advances // Nat. Rev. Cancer. 2018. Vol. 18, N 3. P. 148–167.
2. Collins R.J., Verschuer L.A., Harmon B.V., Prentice R.L., Pope J.H., Kerr J.F. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro // Br. J. Haematol. 1989. Vol. 71, N 3. P. 343–350.
3. Panayiotidis P., Jones D., Ganeshaguru K., Foroni L., Hoffbrand A.V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro // Br. J. Haematol. 1996. Vol. 92, N 1. P. 97–103.
4. Lagneaux L., Delforge A., De Bruyn C., Bernier M., Bron D. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells // Leuk. Lymphoma. 1999. Vol. 35, N 5–6. 445–453.
5. Burger J.A., Tsukada N., Burger M., Zvaifler N.J., Dell’Aquila M., Kipps T.J. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1 // Blood. 2000. Vol. 96, N 8. P. 2655–2663.
6. Pedersen I.M., Kitada S., Leoni L.M., Zapata J.M., Karras J.G., Tsukada N. et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1 // Blood. 2002. Vol. 100, N 5. P. 1795–1801.
7. Hwang K.K., Chen X., Kozink D.M., Gustilo M., Marshall D.J., Whitesides J.F. et al. Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells // Blood. 2012. Vol. 119, N 7. P. e35–e44.
8. Herndon T.M., Chen S.S., Saba N.S., Valdez J., Emson C., Gatmaitan M. et al. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood // Leukemia. 2017. Vol. 31, N 6. P. 1340–1347.
9. Herishanu Y., Perez-Galan P., Liu D., Biancotto A., Pittaluga S., Vire B. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia // Blood. 2011. Vol. 117, N 2. P. 563–574.
10. Burger J.A., O’Brien S. Evolution of CLL treatment – from chemoimmunotherapy to targeted and individualized therapy // Nat. Rev. Clin. Oncol. 2018. Vol. 15, N 8. P. 510–527.
11. Caligaris-Cappio F., Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? // J. Clin. Oncol. 2008. Vol. 26, N 27. P. 4497–4503.
12. Messmer B.T., Messmer D., Allen S.L., Kolitz J.E., Kudalkar P., Cesar D. et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells // J. Clin. Invest. 2005. Vol. 115, N 3. P. 755–764.
13. Ponzoni M., Doglioni C., Caligaris-Cappio F. Chronic lymphocytic leukemia: the pathologist’s view of lymph node microenvironment // Semin. Diagn. Pathol. 2011. Vol. 28, N 2. P. 161–166.
14. Inamdar K.V., Bueso-Ramos C.E. Pathology of chronic lymphocytic leukemia: an update // Ann. Diagn. Pathol. 2007. Vol. 11, N 5. P. 363–389.
15. Lampert I.A., Wotherspoon A., Van Noorden S., Hasserjian R.P. High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen // Hum. Pathol. 1999. Vol. 30, N 6. P. 648–654.
16. Ding W., Nowakowski G.S., Knox T.R., Boysen J.C., Maas M.L., Schwager S.M. et al. Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression // Br. J. Haematol. 2009. Vol. 147, N 4. P. 471–483.
17. Ruan J., Hyjek E., Kermani P., Christos P.J., Hooper A.T., Coleman M. et al. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin’s lymphoma // Clin. Cancer Res. 2006. Vol. 12, N 19. P. 5622–5631.
18. Kurtova A.V., Balakrishnan K., Chen R., Ding W., Schnabl S., Quiroga M.P. et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance // Blood. 2009. Vol. 114, N 20. P. 4441–4450.
19. Burger J.A., Burger M., Kipps T.J. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells // Blood. 1999. Vol. 94, N 11. P. 3658–3667.
20. Burger J.A., Ghia P., Rosenwald A., Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies // Blood. 2009. Vol. 114, N 16. P. 3367–3375.
21. Burger M., Hartmann T., Krome M., Rawluk J., Tamamura H., Fujii N. et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells // Blood. 2005. Vol. 106, N 5. P. 1824–1830.
22. Purroy N., Abrisqueta P., Carabia J., Carpio C., Palacio C., Bosch F. et al. Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo // Oncotarget. 2015. Vol. 6, N 10. P. 7632–7643.
23. Giannoni P., Scaglione S., Quarto R., Narcisi R., Parodi M., Balleari E. et al. An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease // Haematologica. 2011. Vol. 96, N 7. P. 1015–1023.
24. de la Fuente M.T., Casanova B., Moyano J.V., Garcia-Gila M., Sanz L., Garcia-Marco J. et al. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine // J. Leukoc. Biol. 2002. Vol. 71, N 3. P. 495–502.